Cytovance Biologics announces Dr John Mott as Vice President of Bioprocess Development of R&D Services
Cytovance Biologics, Inc., a leading full-service contract biopharmaceutical manufacturer, has announced the addition of Dr John Mott as Vice President of Bioprocess Development